{
  "main_header": {
    "sid": 653435,
    "name": "Orchid Pharma",
    "stock_name": "Orchid Pharma",
    "full_name": "Orchid Pharma Ltd",
    "name_url": "stocks-analysis/orchid-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "526.55",
    "chg": 9.55,
    "chgp": "1.85%",
    "dir": 1,
    "prev_price": "517.00",
    "mcapval": "2,579.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524372,
    "symbol": "ORCHPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE191A01027",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "1.54 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/orchid-pharma-653435-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "653435",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/orchid-pharma-653435"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Intimation of Trading Window Closure for Quarter IV for the Financial Year 2025-26 ending on March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (Amalgamating Company) With Orchid Pharma Limited (Amalgamated Company) And Their Respective Shareholders And Creditors (The Scheme) Under Regulation 30 Of SEBI (Listing Obligati",
      "datetime": "18-Mar-2026",
      "details": "Update related to the Scheme of Amalgamation of Dhanuka Laboratories Limited (Amalgamating Company) with Orchid Pharma Limited (Amalgamated Company) and their respective shareholders and creditors (the scheme) under regulation 30 of SEBI (Listing Obligations and Disclosure) Requirement Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "16-Feb-2026",
      "details": "Transcript of Analysts/ Investors Earning call held with Public at large on February 12 2026 through tele-conferencing.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12",
          "dt": "2012-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News